These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 37990271)

  • 1. LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability.
    Han L; Jiang Y; Shi M; Gan L; Wu Z; Xue M; Zhu Y; Xiong C; Wang T; Lin X; Shen B; Jiang L; Chen H
    J Transl Med; 2023 Nov; 21(1):838. PubMed ID: 37990271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Purinergic Receptor P2Y2 Prevents the Growth of Pancreatic Ductal Adenocarcinoma by Inhibiting Cancer Cell Glycolysis.
    Hu LP; Zhang XX; Jiang SH; Tao LY; Li Q; Zhu LL; Yang MW; Huo YM; Jiang YS; Tian GA; Cao XY; Zhang YL; Yang Q; Yang XM; Wang YH; Li J; Xiao GG; Sun YW; Zhang ZG
    Clin Cancer Res; 2019 Feb; 25(4):1318-1330. PubMed ID: 30420446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALDOA functions as an oncogene in the highly metastatic pancreatic cancer.
    Ji S; Zhang B; Liu J; Qin Y; Liang C; Shi S; Jin K; Liang D; Xu W; Xu H; Wang W; Wu C; Liu L; Liu C; Xu J; Ni Q; Yu X
    Cancer Lett; 2016 Apr; 374(1):127-135. PubMed ID: 26854714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldolase A promotes proliferation and G
    Fu H; Gao H; Qi X; Zhao L; Wu D; Bai Y; Li H; Liu X; Hu J; Shao S
    Cancer Commun (Lond); 2018 May; 38(1):18. PubMed ID: 29764507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycolysis and tumor progression promoted by the m
    Yang K; Zhong Z; Zou J; Liao JY; Chen S; Zhou S; Zhao Y; Li J; Yin D; Huang K; Li Y
    Cancer Lett; 2024 May; 590():216840. PubMed ID: 38604311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Serotonin Signaling Contributes to the Warburg Effect in Pancreatic Tumor Cells Under Metabolic Stress and Promotes Growth of Pancreatic Tumors in Mice.
    Jiang SH; Li J; Dong FY; Yang JY; Liu DJ; Yang XM; Wang YH; Yang MW; Fu XL; Zhang XX; Li Q; Pang XF; Huo YM; Li J; Zhang JF; Lee HY; Lee SJ; Qin WX; Gu JR; Sun YW; Zhang ZG
    Gastroenterology; 2017 Jul; 153(1):277-291.e19. PubMed ID: 28315323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromedin U regulates the anti-tumor activity of CD8
    Zheng R; Wang S; Wang J; Zhou M; Shi Q; Liu B
    Cancer Sci; 2024 Feb; 115(2):334-346. PubMed ID: 38071753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA AB209630 inhibits gemcitabine resistance cell proliferation by regulating PI3K/AKT signaling in pancreatic ductal adenocarcinoma.
    Wang L; Wang F; Na L; Yu J; Huang L; Meng ZQ; Chen Z; Chen H; Ming LL; Hua YQ
    Cancer Biomark; 2018; 22(1):169-174. PubMed ID: 29526843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CRABP-II overcomes pancreatic cancer drug resistance by reversing lipid raft cholesterol accumulation and AKT survival signaling.
    Yu S; Wang L; Che D; Zhang M; Li M; Naito M; Xin W; Zhou L
    J Exp Clin Cancer Res; 2022 Mar; 41(1):88. PubMed ID: 35260193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IRAK2-NF-κB signaling promotes glycolysis-dependent tumor growth in pancreatic cancer.
    Yang J; Liu DJ; Zheng JH; He RZ; Xu DP; Yang MW; Yao HF; Fu XL; Yang JY; Huo YM; Tao LY; Hua R; Sun YW; Kong XM; Jiang SH; Liu W
    Cell Oncol (Dordr); 2022 Jun; 45(3):367-379. PubMed ID: 35486320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway.
    Zheng S; Hu C; Lin H; Li G; Xia R; Zhang X; Su D; Li Z; Zhou Q; Chen R
    J Exp Clin Cancer Res; 2022 Feb; 41(1):71. PubMed ID: 35189958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NUSAP1-LDHA-Glycolysis-Lactate feedforward loop promotes Warburg effect and metastasis in pancreatic ductal adenocarcinoma.
    Chen M; Cen K; Song Y; Zhang X; Liou YC; Liu P; Huang J; Ruan J; He J; Ye W; Wang T; Huang X; Yang J; Jia Y; Liang X; Shen P; Wang Q; Liang T
    Cancer Lett; 2023 Jul; 567():216285. PubMed ID: 37354982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the Nampt-mediated NAD salvage pathway and its therapeutic implications in pancreatic cancer.
    Ju HQ; Zhuang ZN; Li H; Tian T; Lu YX; Fan XQ; Zhou HJ; Mo HY; Sheng H; Chiao PJ; Xu RH
    Cancer Lett; 2016 Aug; 379(1):1-11. PubMed ID: 27233476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel circular RNA circSLIT2 facilitates the aerobic glycolysis of pancreatic ductal adenocarcinoma via miR-510-5p/c-Myc/LDHA axis.
    Guan H; Luo W; Liu Y; Li M
    Cell Death Dis; 2021 Jun; 12(7):645. PubMed ID: 34168116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting ONECUT3 blocks glycolytic metabolism and potentiates anti-PD-1 therapy in pancreatic cancer.
    Chen PC; Ning Y; Li H; Su JG; Shen JB; Feng QC; Jiang SH; Shi PD; Guo RS
    Cell Oncol (Dordr); 2024 Feb; 47(1):81-96. PubMed ID: 37606818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.
    Shang M; Weng L; Xu G; Wu S; Liu B; Yin X; Mao A; Zou X; Wang Z
    J Cell Physiol; 2021 Oct; 236(10):6868-6883. PubMed ID: 33629745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MKL-1-induced PINK1-AS overexpression contributes to the malignant progression of hepatocellular carcinoma via ALDOA-mediated glycolysis.
    Wang J; Zhang HM; Dai ZT; Huang Y; Liu H; Chen Z; Wu Y; Liao XH
    Sci Rep; 2022 Dec; 12(1):21283. PubMed ID: 36494481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RETSAT associates with DDX39B to promote fork restarting and resistance to gemcitabine based chemotherapy in pancreatic ductal adenocarcinoma.
    Tu Q; Liu X; Yao X; Li R; Liu G; Jiang H; Li K; Chen Q; Huang X; Chang Q; Xu G; Zhu H; Shi P; Zhao B
    J Exp Clin Cancer Res; 2022 Sep; 41(1):274. PubMed ID: 36109793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.